Results 181 to 190 of about 66,098 (241)

KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors. [PDF]

open access: yesNPJ Precis Oncol
Uras IZ   +9 more
europepmc   +1 more source

Cardiotoxic Effects of Osimertinib Compared to Other EGFR Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

open access: yesCardiovasc Toxicol
Garcia A   +8 more
europepmc   +1 more source

Targeting HER2-Positive HCC1954 Breast Cancer Cells by Novel Thiazole-Dihydrobenzisoxazoles: In-Depth Design, Synthesis and Initial <i>In Vitro</i> Study. [PDF]

open access: yesOncol Res
Piven YA   +8 more
europepmc   +1 more source

HER2 expression and <i>HER2</i> gene amplification in thymic epithelial tumors: a narrative review. [PDF]

open access: yesMediastinum
Agrafiotis AC   +7 more
europepmc   +1 more source

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes. [PDF]

open access: yesFEBS J
Vaparanta K   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy